Floatz logo

465 assets in Obesity Disorder

Therapeutic assets addressing Obesity Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
asc30
Obesity Disorder
Ascletis Pharma (China) Co., LimitedP2BBB (73)
Cagrilintide
Obesity Disorder
Novo Nordisk A/SP3BBB (73)
Efsubaglutide Alfa
Obesity Disorder
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolP4BBB (73)
Phentermine
Obesity Disorder
Russell McCulloh, MDP4BBB (73)
Survodutide
Obesity Disorder
Boehringer IngelheimP3BBB (73)
Tirzepatide
Obesity Disorder
Royal North Shore HospitalP4BBB (73)
Semaglutide
Obesity Disorder
Ali AminianP4BBB (72)
Mazdutide
Obesity Disorder
China National Center for Cardiovascular DiseasesP4BB (70)
Sibutramine
Obesity Disorder
FalquetomedP4BB (70)
Exenatide
Obesity Disorder
Vivani Medical, IncP4BB (69)
Liraglutide
Obesity Disorder
Ali AminianP4BB (69)
Miricorilant
Obesity Disorder
Corcept TherapeuticsP2BB (69)
Naltrexone
Obesity Disorder
Yale UniversityP4BB (69)
da-302168s
Obesity Disorder
Chendu DIAO Pharmaceutical Group CO., LTD.P3BB (68)
Dexmedetomidine
Obesity Disorder
Tanta UniversityP4BB (68)
hdm1002
Obesity Disorder
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.P3BB (68)
hrs9531
Obesity Disorder
Fujian Shengdi Pharmaceutical Co., Ltd.P3BB (68)
Metformin
Obesity Disorder
Ali AminianP4BB (68)
Orforglipron
Obesity Disorder
Eli Lilly and CompanyP3BB (68)
Orlistat
Obesity Disorder
The Fourth Affiliated Hospital of Zhejiang University School of MedicineP4BB (68)
Testosterone Undecylate
Obesity Disorder
Royal College of Surgeons, IrelandP4BB (68)
Topiramate
Obesity Disorder
Ali AminianP4BB (68)
azd6234
Obesity Disorder
AstraZenecaP2BB (67)
Dapagliflozin
Obesity Disorder
Sultan Qaboos UniversityP4BB (67)
Glucagon
Obesity Disorder
Columbia UniversityP4BB (67)
Letrozole
Obesity Disorder
Sultan Qaboos UniversityP4BB (67)
Rybelsus
Obesity Disorder
PfizerP2/3BB (67)
Amlodipine
Obesity Disorder
Vanderbilt University Medical CenterP4BB (66)
Aspirin
Obesity Disorder
Fundació d'investigació Sanitària de les Illes BalearsP4BB (66)
Lorcaserin
Obesity Disorder
Kanion & Huawe Medicine Co.,LtdP4BB (66)
Oxytocin
Obesity Disorder
University Hospital, Gentofte, CopenhagenP4BB (66)
Propofol
Obesity Disorder
Ataturk UniversityP4BB (66)
Sitagliptin
Obesity Disorder
Brigham and Women's HospitalP4BB (66)
Degarelix
Obesity Disorder
University of Colorado, DenverP4BB (65)
Henagliflozin
Obesity Disorder
The First People's Hospital of ChangzhouP4BB (65)
Levonorgestrel
Obesity Disorder
AmgenP4BB (65)
Tripro-Amylin
Obesity Disorder
University Hospital, Gentofte, CopenhagenP2/3BB (65)
Ursodeoxycholic Acid
Obesity Disorder
Ain Shams UniversityP4BB (65)
Atorvastatin
Obesity Disorder
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.P4BB (64)
azd5004
Obesity Disorder
EccogeneP2BB (64)
azd9550
Obesity Disorder
AstraZenecaP2BB (64)
Empagliflozin
Obesity Disorder
Ali AminianP4BB (64)
Enicepatide
Obesity Disorder
Hoffmann-La RocheP3BB (64)
hd1916
Obesity Disorder
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.P3BB (64)
Hydrochlorothiazide
Obesity Disorder
University of Kansas Medical CenterP4BB (64)
Lidocaine
Obesity Disorder
IVO JURISICP4BB (64)
Retatrutide
Obesity Disorder
Hudson BiotechP3BB (64)
tg103
Obesity Disorder
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.P3BB (64)
ubt251
Obesity Disorder
The United Bio-Technology (Hengqin) Co., Ltd.P3BB (64)
Showing 1 to 50 of 465 assets
PreviousPage 1 of 10Next